Structure

Physi-Chem Properties

Molecular Weight:  454.14
Volume:  462.609
LogP:  4.101
LogD:  3.175
LogS:  -4.039
# Rotatable Bonds:  2
TPSA:  110.38
# H-Bond Aceptor:  6
# H-Bond Donor:  5
# Rings:  6
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.293
Synthetic Accessibility Score:  3.946
Fsp3:  0.143
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.555
MDCK Permeability:  7.351337899308419e-06
Pgp-inhibitor:  0.123
Pgp-substrate:  0.964
Human Intestinal Absorption (HIA):  0.391
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.623

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.008
Plasma Protein Binding (PPB):  97.35635375976562%
Volume Distribution (VD):  0.878
Pgp-substrate:  3.0500104427337646%

ADMET: Metabolism

CYP1A2-inhibitor:  0.113
CYP1A2-substrate:  0.816
CYP2C19-inhibitor:  0.943
CYP2C19-substrate:  0.106
CYP2C9-inhibitor:  0.922
CYP2C9-substrate:  0.995
CYP2D6-inhibitor:  0.894
CYP2D6-substrate:  0.854
CYP3A4-inhibitor:  0.591
CYP3A4-substrate:  0.528

ADMET: Excretion

Clearance (CL):  9.252
Half-life (T1/2):  0.238

ADMET: Toxicity

hERG Blockers:  0.079
Human Hepatotoxicity (H-HT):  0.058
Drug-inuced Liver Injury (DILI):  0.651
AMES Toxicity:  0.397
Rat Oral Acute Toxicity:  0.619
Maximum Recommended Daily Dose:  0.684
Skin Sensitization:  0.936
Carcinogencity:  0.23
Eye Corrosion:  0.003
Eye Irritation:  0.88
Respiratory Toxicity:  0.133

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC182509

Natural Product ID:  NPC182509
Common Name*:   BRKQVFGKIFSZIN-QWMXJGQVSA-N
IUPAC Name:   n.a.
Synonyms:   (+)-Ampelopsin A
Standard InCHIKey:  BRKQVFGKIFSZIN-QWMXJGQVSA-N
Standard InCHI:  InChI=1S/C28H22O6/c29-16-8-4-14(5-9-16)23-20-12-18(31)13-21(32)24(20)26-25-19(27(23)33)2-1-3-22(25)34-28(26)15-6-10-17(30)11-7-15/h1-13,23,26-33H/t23-,26-,27-,28+/m0/s1
SMILES:  c1cc2c3c(c1)O[C@H](c1ccc(cc1)O)[C@H]3c1c(cc(cc1O)O)[C@H](c1ccc(cc1)O)[C@H]2O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL601296
PubChem CID:   46230149
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5271.1 Ampelopsis glandulosa var. brevipedunculata Varieties Vitaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO5271.1 Ampelopsis glandulosa var. brevipedunculata Varieties Vitaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT878 Organism Streptococcus mutans Streptococcus mutans IZ < 11.0 mm PMID[519999]
NPT878 Organism Streptococcus mutans Streptococcus mutans IZ < 15.0 mm PMID[519999]
NPT878 Organism Streptococcus mutans Streptococcus mutans IZ = 20.0 mm PMID[519999]
NPT1172 Organism Streptococcus sanguinis Streptococcus sanguinis IZ < 11.0 mm PMID[519999]
NPT1172 Organism Streptococcus sanguinis Streptococcus sanguinis IZ < 15.0 mm PMID[519999]
NPT1172 Organism Streptococcus sanguinis Streptococcus sanguinis IZ = 20.0 mm PMID[519999]
NPT878 Organism Streptococcus mutans Streptococcus mutans MIC = 200.0 ug.mL-1 PMID[519999]
NPT878 Organism Streptococcus mutans Streptococcus mutans MBC = 200.0 ug ml-1 PMID[519999]
NPT1172 Organism Streptococcus sanguinis Streptococcus sanguinis MIC > 400.0 ug.mL-1 PMID[519999]
NPT1172 Organism Streptococcus sanguinis Streptococcus sanguinis MBC > 400.0 ug ml-1 PMID[519999]
NPT878 Organism Streptococcus mutans Streptococcus mutans Activity = 100.0 ug ml-1 PMID[519999]
NPT1172 Organism Streptococcus sanguinis Streptococcus sanguinis Activity > 200.0 ug ml-1 PMID[519999]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC182509 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC174787
1.0 High Similarity NPC213607
0.9697 High Similarity NPC11727
0.9697 High Similarity NPC15109
0.9478 High Similarity NPC141717
0.9429 High Similarity NPC329836
0.9403 High Similarity NPC125579
0.9348 High Similarity NPC163508
0.9348 High Similarity NPC173203
0.9281 High Similarity NPC15659
0.9281 High Similarity NPC304894
0.922 High Similarity NPC224921
0.922 High Similarity NPC242774
0.922 High Similarity NPC237546
0.922 High Similarity NPC111134
0.922 High Similarity NPC231712
0.9098 High Similarity NPC471518
0.9098 High Similarity NPC471519
0.9091 High Similarity NPC122980
0.9091 High Similarity NPC180605
0.9091 High Similarity NPC148516
0.9091 High Similarity NPC177172
0.9091 High Similarity NPC107862
0.9078 High Similarity NPC149633
0.9014 High Similarity NPC71686
0.9014 High Similarity NPC176804
0.8966 High Similarity NPC105073
0.8966 High Similarity NPC224528
0.8966 High Similarity NPC233886
0.8963 High Similarity NPC473309
0.8951 High Similarity NPC6702
0.8951 High Similarity NPC112819
0.8951 High Similarity NPC133209
0.8905 High Similarity NPC476616
0.8905 High Similarity NPC476617
0.8905 High Similarity NPC476615
0.8905 High Similarity NPC473107
0.8904 High Similarity NPC233467
0.8889 High Similarity NPC227516
0.8889 High Similarity NPC254000
0.8889 High Similarity NPC20757
0.8881 High Similarity NPC47283
0.8881 High Similarity NPC14468
0.8881 High Similarity NPC39064
0.8872 High Similarity NPC262573
0.8872 High Similarity NPC471215
0.8832 High Similarity NPC469610
0.8824 High Similarity NPC236014
0.8824 High Similarity NPC237424
0.8824 High Similarity NPC164574
0.8824 High Similarity NPC300875
0.8824 High Similarity NPC228369
0.8824 High Similarity NPC196765
0.8824 High Similarity NPC12875
0.8824 High Similarity NPC206224
0.8824 High Similarity NPC476166
0.8824 High Similarity NPC129784
0.8824 High Similarity NPC238168
0.8824 High Similarity NPC118114
0.8824 High Similarity NPC17343
0.8824 High Similarity NPC207892
0.8824 High Similarity NPC129106
0.8824 High Similarity NPC150011
0.8824 High Similarity NPC268917
0.8824 High Similarity NPC280653
0.8824 High Similarity NPC8899
0.8797 High Similarity NPC113495
0.8794 High Similarity NPC178054
0.8794 High Similarity NPC100482
0.8794 High Similarity NPC277331
0.8777 High Similarity NPC471522
0.8776 High Similarity NPC473018
0.8776 High Similarity NPC120633
0.8768 High Similarity NPC225696
0.8768 High Similarity NPC198154
0.8768 High Similarity NPC296915
0.8768 High Similarity NPC97834
0.8768 High Similarity NPC223008
0.8768 High Similarity NPC115335
0.8767 High Similarity NPC218801
0.8759 High Similarity NPC469611
0.8759 High Similarity NPC13005
0.875 High Similarity NPC27187
0.875 High Similarity NPC470225
0.8731 High Similarity NPC230479
0.8731 High Similarity NPC50315
0.8731 High Similarity NPC26879
0.8731 High Similarity NPC283049
0.8723 High Similarity NPC22317
0.8714 High Similarity NPC470308
0.8714 High Similarity NPC470307
0.8714 High Similarity NPC474390
0.8707 High Similarity NPC324517
0.8707 High Similarity NPC329343
0.8707 High Similarity NPC157081
0.8707 High Similarity NPC321972
0.8705 High Similarity NPC258780
0.869 High Similarity NPC58190
0.869 High Similarity NPC262911
0.869 High Similarity NPC18185
0.869 High Similarity NPC70409
0.869 High Similarity NPC204770
0.869 High Similarity NPC236202
0.869 High Similarity NPC82917
0.869 High Similarity NPC202742
0.869 High Similarity NPC263940
0.869 High Similarity NPC294558
0.869 High Similarity NPC108811
0.869 High Similarity NPC170103
0.8686 High Similarity NPC472590
0.8686 High Similarity NPC271945
0.8686 High Similarity NPC162801
0.8686 High Similarity NPC282508
0.8686 High Similarity NPC181497
0.8686 High Similarity NPC471517
0.8684 High Similarity NPC48880
0.8658 High Similarity NPC157333
0.8652 High Similarity NPC475836
0.8649 High Similarity NPC476391
0.8649 High Similarity NPC59692
0.8643 High Similarity NPC234952
0.8643 High Similarity NPC133463
0.8643 High Similarity NPC472649
0.8643 High Similarity NPC170328
0.8643 High Similarity NPC206525
0.8643 High Similarity NPC472647
0.8643 High Similarity NPC191462
0.8643 High Similarity NPC472648
0.8621 High Similarity NPC324492
0.8621 High Similarity NPC96576
0.8621 High Similarity NPC260397
0.8621 High Similarity NPC317053
0.8611 High Similarity NPC28440
0.8611 High Similarity NPC171932
0.8603 High Similarity NPC38664
0.8603 High Similarity NPC53986
0.8603 High Similarity NPC274717
0.8592 High Similarity NPC27495
0.8592 High Similarity NPC184797
0.8592 High Similarity NPC309124
0.8582 High Similarity NPC477938
0.8582 High Similarity NPC256015
0.8582 High Similarity NPC71465
0.8582 High Similarity NPC294156
0.8582 High Similarity NPC472646
0.8571 High Similarity NPC470826
0.8571 High Similarity NPC211561
0.8571 High Similarity NPC473266
0.8571 High Similarity NPC37410
0.8571 High Similarity NPC470098
0.8562 High Similarity NPC327412
0.8562 High Similarity NPC320671
0.8562 High Similarity NPC320970
0.8562 High Similarity NPC328567
0.8561 High Similarity NPC85435
0.8552 High Similarity NPC181615
0.8551 High Similarity NPC68205
0.8551 High Similarity NPC244888
0.8551 High Similarity NPC293203
0.8551 High Similarity NPC118683
0.8551 High Similarity NPC164804
0.8551 High Similarity NPC211413
0.854 High Similarity NPC472797
0.854 High Similarity NPC93962
0.8531 High Similarity NPC263261
0.8531 High Similarity NPC5155
0.8531 High Similarity NPC87725
0.8521 High Similarity NPC32630
0.8521 High Similarity NPC232164
0.8521 High Similarity NPC471388
0.8521 High Similarity NPC473739
0.8521 High Similarity NPC55947
0.8521 High Similarity NPC236306
0.8519 High Similarity NPC81641
0.8516 High Similarity NPC474591
0.8514 High Similarity NPC477612
0.8511 High Similarity NPC327735
0.8511 High Similarity NPC126101
0.8511 High Similarity NPC18189
0.8511 High Similarity NPC262585
0.8511 High Similarity NPC20829
0.8507 High Similarity NPC38761
0.8507 High Similarity NPC76465
0.85 High Similarity NPC256307
0.85 High Similarity NPC124085
0.85 High Similarity NPC117048
0.85 High Similarity NPC66840
0.8496 Intermediate Similarity NPC54972
0.8496 Intermediate Similarity NPC193364
0.8493 Intermediate Similarity NPC102280
0.8493 Intermediate Similarity NPC215678
0.8493 Intermediate Similarity NPC274454
0.8493 Intermediate Similarity NPC248053
0.8493 Intermediate Similarity NPC155564
0.8483 Intermediate Similarity NPC475492
0.8483 Intermediate Similarity NPC471415
0.8483 Intermediate Similarity NPC473108
0.8483 Intermediate Similarity NPC470097
0.8483 Intermediate Similarity NPC114119
0.8477 Intermediate Similarity NPC202104

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC182509 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8881 High Similarity NPD4908 Phase 1
0.875 High Similarity NPD4907 Clinical (unspecified phase)
0.8496 Intermediate Similarity NPD1610 Phase 2
0.8394 Intermediate Similarity NPD2861 Phase 2
0.8357 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8357 Intermediate Similarity NPD1613 Approved
0.8195 Intermediate Similarity NPD1548 Phase 1
0.8143 Intermediate Similarity NPD4625 Phase 3
0.8071 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8014 Intermediate Similarity NPD3027 Phase 3
0.8 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7971 Intermediate Similarity NPD4749 Approved
0.7958 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7852 Intermediate Similarity NPD3892 Phase 2
0.7785 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7763 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.775 Intermediate Similarity NPD6959 Discontinued
0.7718 Intermediate Similarity NPD7037 Approved
0.7697 Intermediate Similarity NPD7212 Phase 2
0.7697 Intermediate Similarity NPD7213 Phase 3
0.7676 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD7447 Phase 1
0.7643 Intermediate Similarity NPD37 Approved
0.764 Intermediate Similarity NPD7199 Phase 2
0.7616 Intermediate Similarity NPD3750 Approved
0.7616 Intermediate Similarity NPD7466 Approved
0.761 Intermediate Similarity NPD4967 Phase 2
0.761 Intermediate Similarity NPD4965 Approved
0.761 Intermediate Similarity NPD4966 Approved
0.7603 Intermediate Similarity NPD4060 Phase 1
0.7593 Intermediate Similarity NPD7229 Phase 3
0.7589 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7551 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7551 Intermediate Similarity NPD5735 Approved
0.7551 Intermediate Similarity NPD5124 Phase 1
0.7547 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD6234 Discontinued
0.75 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7768 Phase 2
0.7483 Intermediate Similarity NPD4140 Approved
0.747 Intermediate Similarity NPD5844 Phase 1
0.7467 Intermediate Similarity NPD6099 Approved
0.7467 Intermediate Similarity NPD6100 Approved
0.7466 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7465 Intermediate Similarity NPD5327 Phase 3
0.7453 Intermediate Similarity NPD3749 Approved
0.7439 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7434 Intermediate Similarity NPD6674 Discontinued
0.7431 Intermediate Similarity NPD6584 Phase 3
0.7417 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7413 Intermediate Similarity NPD6696 Suspended
0.741 Intermediate Similarity NPD7228 Approved
0.7394 Intermediate Similarity NPD6166 Phase 2
0.7394 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7381 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD1549 Phase 2
0.7365 Intermediate Similarity NPD2238 Phase 2
0.7355 Intermediate Similarity NPD7041 Phase 2
0.7355 Intermediate Similarity NPD7040 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD1091 Approved
0.7324 Intermediate Similarity NPD422 Phase 1
0.7319 Intermediate Similarity NPD6671 Approved
0.7312 Intermediate Similarity NPD1934 Approved
0.7308 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD5763 Approved
0.7303 Intermediate Similarity NPD5762 Approved
0.7296 Intermediate Similarity NPD4380 Phase 2
0.7285 Intermediate Similarity NPD3748 Approved
0.7285 Intermediate Similarity NPD5588 Approved
0.7273 Intermediate Similarity NPD3787 Discontinued
0.7267 Intermediate Similarity NPD4097 Suspended
0.7267 Intermediate Similarity NPD7819 Suspended
0.7267 Intermediate Similarity NPD6353 Approved
0.7267 Intermediate Similarity NPD8455 Phase 2
0.7248 Intermediate Similarity NPD3620 Phase 2
0.7248 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD3094 Phase 2
0.7239 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.723 Intermediate Similarity NPD6812 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6583 Phase 3
0.7222 Intermediate Similarity NPD6582 Phase 2
0.7202 Intermediate Similarity NPD3818 Discontinued
0.7197 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7183 Intermediate Similarity NPD6516 Phase 2
0.7183 Intermediate Similarity NPD5846 Approved
0.7172 Intermediate Similarity NPD8651 Approved
0.7171 Intermediate Similarity NPD1510 Phase 2
0.7171 Intermediate Similarity NPD7033 Discontinued
0.717 Intermediate Similarity NPD1653 Approved
0.7164 Intermediate Similarity NPD968 Approved
0.7163 Intermediate Similarity NPD3091 Approved
0.7161 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7153 Intermediate Similarity NPD1840 Phase 2
0.7153 Intermediate Similarity NPD2231 Phase 2
0.7153 Intermediate Similarity NPD2235 Phase 2
0.7152 Intermediate Similarity NPD5494 Approved
0.7152 Intermediate Similarity NPD6273 Approved
0.7143 Intermediate Similarity NPD3018 Phase 2
0.7143 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7411 Suspended
0.7135 Intermediate Similarity NPD6559 Discontinued
0.7134 Intermediate Similarity NPD1511 Approved
0.7132 Intermediate Similarity NPD4750 Phase 3
0.7124 Intermediate Similarity NPD2796 Approved
0.7115 Intermediate Similarity NPD2677 Approved
0.7114 Intermediate Similarity NPD6798 Discontinued
0.711 Intermediate Similarity NPD8054 Approved
0.711 Intermediate Similarity NPD8053 Approved
0.7105 Intermediate Similarity NPD4536 Approved
0.7105 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD4538 Approved
0.7097 Intermediate Similarity NPD1652 Phase 2
0.7089 Intermediate Similarity NPD4160 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD2532 Approved
0.7089 Intermediate Similarity NPD2534 Approved
0.7089 Intermediate Similarity NPD7446 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD2533 Approved
0.7086 Intermediate Similarity NPD6355 Discontinued
0.7083 Intermediate Similarity NPD3705 Approved
0.7083 Intermediate Similarity NPD3092 Approved
0.7078 Intermediate Similarity NPD6002 Phase 3
0.7078 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD6005 Phase 3
0.7078 Intermediate Similarity NPD6004 Phase 3
0.7075 Intermediate Similarity NPD4624 Approved
0.7073 Intermediate Similarity NPD3882 Suspended
0.7071 Intermediate Similarity NPD7157 Approved
0.707 Intermediate Similarity NPD5058 Phase 3
0.7066 Intermediate Similarity NPD6232 Discontinued
0.7059 Intermediate Similarity NPD5960 Phase 3
0.7059 Intermediate Similarity NPD2684 Approved
0.7055 Intermediate Similarity NPD2801 Approved
0.7052 Intermediate Similarity NPD8312 Approved
0.7052 Intermediate Similarity NPD8313 Approved
0.705 Intermediate Similarity NPD5283 Phase 1
0.7045 Intermediate Similarity NPD1242 Phase 1
0.7044 Intermediate Similarity NPD1512 Approved
0.7041 Intermediate Similarity NPD7473 Discontinued
0.7039 Intermediate Similarity NPD2157 Approved
0.7035 Intermediate Similarity NPD7240 Approved
0.7029 Intermediate Similarity NPD4663 Approved
0.7027 Intermediate Similarity NPD1712 Approved
0.7018 Intermediate Similarity NPD7074 Phase 3
0.7014 Intermediate Similarity NPD3496 Discontinued
0.7012 Intermediate Similarity NPD5402 Approved
0.7012 Intermediate Similarity NPD2560 Approved
0.7012 Intermediate Similarity NPD2563 Approved
0.7007 Intermediate Similarity NPD2797 Approved
0.7 Intermediate Similarity NPD3751 Discontinued
0.7 Intermediate Similarity NPD3764 Approved
0.6994 Remote Similarity NPD7549 Discontinued
0.6993 Remote Similarity NPD3445 Approved
0.6993 Remote Similarity NPD3444 Approved
0.6993 Remote Similarity NPD3443 Approved
0.6993 Remote Similarity NPD7097 Phase 1
0.6992 Remote Similarity NPD940 Approved
0.6992 Remote Similarity NPD846 Approved
0.6987 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6986 Remote Similarity NPD2982 Phase 2
0.6986 Remote Similarity NPD2983 Phase 2
0.6986 Remote Similarity NPD3685 Discontinued
0.6985 Remote Similarity NPD290 Approved
0.6978 Remote Similarity NPD5535 Approved
0.6978 Remote Similarity NPD7843 Approved
0.6964 Remote Similarity NPD3051 Approved
0.6959 Remote Similarity NPD7054 Approved
0.6959 Remote Similarity NPD8156 Discontinued
0.6954 Remote Similarity NPD4578 Approved
0.6954 Remote Similarity NPD6233 Phase 2
0.6954 Remote Similarity NPD4577 Approved
0.6951 Remote Similarity NPD1465 Phase 2
0.6944 Remote Similarity NPD3095 Discontinued
0.6944 Remote Similarity NPD4626 Approved
0.6939 Remote Similarity NPD3225 Approved
0.6933 Remote Similarity NPD7095 Approved
0.6928 Remote Similarity NPD7075 Discontinued
0.6923 Remote Similarity NPD1182 Approved
0.6923 Remote Similarity NPD2969 Approved
0.6923 Remote Similarity NPD2970 Approved
0.6923 Remote Similarity NPD7741 Discontinued
0.6919 Remote Similarity NPD7472 Approved
0.6918 Remote Similarity NPD1608 Approved
0.6918 Remote Similarity NPD2230 Approved
0.6918 Remote Similarity NPD2233 Approved
0.6918 Remote Similarity NPD2981 Phase 2
0.6918 Remote Similarity NPD7390 Discontinued
0.6918 Remote Similarity NPD2232 Approved
0.6914 Remote Similarity NPD4005 Discontinued
0.6914 Remote Similarity NPD8158 Clinical (unspecified phase)
0.6909 Remote Similarity NPD6374 Clinical (unspecified phase)
0.6908 Remote Similarity NPD1240 Approved
0.6908 Remote Similarity NPD5837 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data